David Deems
Directeur Général chez Xceed Molecular Corp.
Profil
David Deems is the founder of Cephos Corp.
He currently holds the position of President & Chief Executive Officer at Xceed Molecular Corp.
and Director at Cellaria Biosciences LLC.
Previously, he served as Chief Executive Officer at FKAUBI, Inc., Vice President-Product Development at EXACT Sciences Corp., Vice President at BD Biosciences, Systems & Reagents, Inc., President-Sales, Marketing & Business Development at Axela, Inc., and Vice President-Operations & Development at Predicant Biosciences, Inc.
Postes actifs de David Deems
| Sociétés | Poste | Début |
|---|---|---|
Xceed Molecular Corp.
 Xceed Molecular Corp. Medical SpecialtiesHealth Technology Xceed Molecular Corporation is a molecular diagnostic company dedicated to commercializing a platform for automated gene expression analysis and developing proprietary clinical research assays and custom arrays. They develop tools and content aimed at accelerating the current market trend towards 'translational medicine', and bridging the gap from gene signature validation to clinical diagnostics. The Ziplex Automated Workstation is the first integrated and fully automated hybridization system for multiplex gene expression signatures. Their integrated solution - the Ziplex System - features this innovative instrument platform and focused-content TipChip arrays and reagents to perform highly multiplexed molecular assays with superior accuracy, reproducibility, speed and scalability. The Ziplex System is designed to provide the ease-of-use in assay automation and analytics that is required to successfully translate gene expression analysis from research use into routine practice. Xceed complements the Ziplex platform by offering Gene Expression Services and Assay Development Services. | Directeur Général | - |
Cellaria Biosciences LLC
 Cellaria Biosciences LLC BiotechnologyHealth Technology Cellaria Biosciences LLC engages in research and development of cancer cure products. The firm offers cancer research custom and stem cell services. The company is headquartered in Wakefield, MA. | Directeur/Membre du Conseil | - |
Anciens postes connus de David Deems
| Sociétés | Poste | Fin |
|---|---|---|
Axela, Inc.
 Axela, Inc. Medical SpecialtiesHealth Technology Axela, Inc. develops biosensor technology. It offers next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. The firm’s products include Ziplex System, autograph, metabolic, colon and breast cancer, inflammation Xpress chips, diffractive optics technology and sensors, dotLab mX System and dot-Avidin, Ready and Covalent products. The company was founded by M. Cynthia Goh, Richard Loo, B. Jane Goh and Richard McAloney in 2001 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | - |
Cephos Corp.
 Cephos Corp. BiotechnologyHealth Technology Cephos Corp. develops biotechnology products. The private company is based in Pepperell, MA. | Corporate Officer/Principal | - |
BD Biosciences, Systems & Reagents, Inc.
 BD Biosciences, Systems & Reagents, Inc. Pharmaceuticals: MajorHealth Technology BD Biosciences, Systems & Reagents, Inc. provides tools and solutions to research and clinical laboratories in basic research, drug discovery, development, biopharmaceutical production and disease management. The company was founded on May 9, 1991 and is headquartered in San Jose, CA. | Corporate Officer/Principal | - |
FKAUBI, Inc.
 FKAUBI, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Harvard Bioscience, Inc., FKAUBI, Inc. is a company that specializes in Union Biometrica publications and UnionBio Applications. The company is based in Somerville, MA. The company offers an introduction to Large Object Flow Cytometry. FKAUBI was acquired by Harvard Bioscience, Inc. on May 31, 2001 for $13.37 million. | President | - |
| EXACT SCIENCES CORPORATION | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EXACT SCIENCES CORPORATION | Health Technology |
| Entreprise privées | 7 |
|---|---|
Xceed Molecular Corp.
Xceed Molecular Corp. Medical SpecialtiesHealth Technology Xceed Molecular Corporation is a molecular diagnostic company dedicated to commercializing a platform for automated gene expression analysis and developing proprietary clinical research assays and custom arrays. They develop tools and content aimed at accelerating the current market trend towards 'translational medicine', and bridging the gap from gene signature validation to clinical diagnostics. The Ziplex Automated Workstation is the first integrated and fully automated hybridization system for multiplex gene expression signatures. Their integrated solution - the Ziplex System - features this innovative instrument platform and focused-content TipChip arrays and reagents to perform highly multiplexed molecular assays with superior accuracy, reproducibility, speed and scalability. The Ziplex System is designed to provide the ease-of-use in assay automation and analytics that is required to successfully translate gene expression analysis from research use into routine practice. Xceed complements the Ziplex platform by offering Gene Expression Services and Assay Development Services. | Health Technology |
Predicant Biosciences, Inc.
 Predicant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Predicant Biosciences, Inc. is a life sciences company, which used to develop minimally invasive technology for identifying and assaying protein biomarker patterns that reflect and differentiate biological states. It was founded in 2002 and was located in San Francisco, CA | Health Technology |
FKAUBI, Inc.
FKAUBI, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Harvard Bioscience, Inc., FKAUBI, Inc. is a company that specializes in Union Biometrica publications and UnionBio Applications. The company is based in Somerville, MA. The company offers an introduction to Large Object Flow Cytometry. FKAUBI was acquired by Harvard Bioscience, Inc. on May 31, 2001 for $13.37 million. | Commercial Services |
BD Biosciences, Systems & Reagents, Inc.
BD Biosciences, Systems & Reagents, Inc. Pharmaceuticals: MajorHealth Technology BD Biosciences, Systems & Reagents, Inc. provides tools and solutions to research and clinical laboratories in basic research, drug discovery, development, biopharmaceutical production and disease management. The company was founded on May 9, 1991 and is headquartered in San Jose, CA. | Health Technology |
Cephos Corp.
Cephos Corp. BiotechnologyHealth Technology Cephos Corp. develops biotechnology products. The private company is based in Pepperell, MA. | Health Technology |
Axela, Inc.
Axela, Inc. Medical SpecialtiesHealth Technology Axela, Inc. develops biosensor technology. It offers next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. The firm’s products include Ziplex System, autograph, metabolic, colon and breast cancer, inflammation Xpress chips, diffractive optics technology and sensors, dotLab mX System and dot-Avidin, Ready and Covalent products. The company was founded by M. Cynthia Goh, Richard Loo, B. Jane Goh and Richard McAloney in 2001 and is headquartered in Toronto, Canada. | Health Technology |
Cellaria Biosciences LLC
Cellaria Biosciences LLC BiotechnologyHealth Technology Cellaria Biosciences LLC engages in research and development of cancer cure products. The firm offers cancer research custom and stem cell services. The company is headquartered in Wakefield, MA. | Health Technology |
